Massachusetts Press Releases

Published on February 25, 2021 - 18:55 GMT

Leading New York State Hospitals Deploy Intelligent New Autonomous Robots to Combat Pandemic

Among the first hospitals in the country to embrace mobile robot for fast, deep, cost-effective disinfecting TYNGSBORO, MASSACHUSETTS, USA, February 25, 2021 /⁨EINPresswire.com⁩/ -- Two leading healthcare providers in New York state recently began …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on February 25, 2021 - 14:11 GMT

LAWSUIT FILED: Ebix, Inc. Sued for Violations of the Federal Securities Laws; Investors Should Contact Block & Leviton LLP

BOSTON, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, announces that a lawsuit for violation of the federal securities laws has been filed against Ebix, Inc. (NASDAQ: EBIX) and …

Distribution channels: Culture, Society & Lifestyle, Law ...

Published on February 25, 2021 - 14:00 GMT

LogMeIn Study Shows Cyber Threats, Productivity Concerns, and Pressure on IT Support Drives Consolidation of Remote Access & ...

BOSTON, Feb. 25, 2021 (GLOBE NEWSWIRE) -- LogMeIn, Inc. a leader in empowering the work-from-anywhere era with solutions such as GoTo, LastPass, and Rescue, today announced results of a global study executed by IDG that reveals the new reality of long-term …

Distribution channels: IT Industry, Media, Advertising & PR ...

Published on February 25, 2021 - 13:31 GMT

AquaBounty Technologies to Attend the Canaccord Genuity 2021 Virtual Sustainability Conference

MAYNARD, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (Nasdaq: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced that management …

Distribution channels: Agriculture, Farming & Forestry Industry, Culture, Society & Lifestyle ...

Published on February 25, 2021 - 13:30 GMT

Spero Therapeutics to Present at Investor Conferences in March

CAMBRIDGE, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi- …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 25, 2021 - 13:00 GMT

Chiasma to Report Fourth Quarter 2020 Results on March 4

NEEDHAM, Maine, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial stage biopharmaceutical company, today announced that it will host a conference call and live audio webcast on Thursday, March 4, 2021 at 5:00 pm Eastern Time to …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 25, 2021 - 13:00 GMT

scPharmaceuticals to Present in Two Upcoming Investor Conferences

BURLINGTON, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on February 25, 2021 - 13:00 GMT

Cue Biopharma Enhances Scientific Advisory Board with Appointments of Immunology and Immunotherapy Experts Dr. Abul K. Abbas and ...

CAMBRIDGE, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (NASDAQ: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics designed to selectively engage and modulate targeted T cells within the …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on February 25, 2021 - 13:00 GMT

Albireo Reports Q4 and Year-End 2020 Financial Results and Business Update

– NDA and MAA for odevixibat accepted, on track for anticipated H2 21 launch – – Announces odevixibat co-promotion agreement with Travere, a leading rare disease company – – ASSERT global pivotal Phase 3 trial in Alagille syndrome initiated and enrolling – …

Distribution channels:

Published on February 25, 2021 - 13:00 GMT

Homology Medicines to Participate in Upcoming Investor and Patient Advocacy Conferences

BEDFORD, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a clinical-stage genetic medicines company, announced today presentations at the following virtual conferences: Cowen 41st Annual Health Care Conference Panel …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 25, 2021 - 13:00 GMT

Conformis, Inc. to Participate in Upcoming Investor Conferences

BILLERICA, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 25, 2021 - 12:30 GMT

Intellia Therapeutics Announces Fourth Quarter and Full-Year 2020 Financial Results

Expects to report initial data from Phase 1 study of NTLA-2001, a potentially curative single-course therapy for transthyretin amyloidosis (ATTR), in 2021 On track to submit an IND or IND-equivalent in mid-2021 for NTLA-5001 for the treatment of acute …

Distribution channels:

Published on February 25, 2021 - 12:30 GMT

DraftKings Welcomes Cal Ripken Jr. as Special Advisor to the Board of Directors

BOSTON, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Today, DraftKings (Nasdaq: DKNG) announced the appointment of baseball legend and entrepreneur Cal Ripken Jr. as a special advisor to the board of directors. Ripken will lend strategic insights to the board of …

Distribution channels: